Lantheus (LNTH)
Commercializes PET radiodiagnostics and ultrasound-enhancing agents for prostate cancer, amyloid, and cardiac imaging.
$99.91
vs last close−0.09 (−0.10%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 43 days
EPS estimate
$1.25
Revenue estimate
$360.9M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$1.59$1.53$1.57$1.27$1.67$1.46$1.55Pending
Estimate$1.58$1.68$1.64$1.27$1.18$1.25$1.30$1.25
Surprise+0.6%−8.9%−4.3%0.0%+41.5%+16.8%+19.2%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$391.1M$372.8M$378.0M$384.0M$406.8M$377.3M$388.2MPending
Estimate$379.5M$395.2M$363.3M$368.0M$367.0M$354.5M$363.2M$360.9M
Surprise+3.1%−5.7%+4.0%+4.4%+10.8%+6.4%+6.9%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $2.60 | — | — |
| Sep 2028 | $1.82 | — | — |
| Jun 2028 | $1.70 | — | — |
| Mar 2028 | $1.55 | — | — |
| Dec 2027 | $1.88 | — | — |
| Sep 2027 | $1.59 | — | — |
| Jun 2027 | $1.52 | — | — |
| Mar 2027 | $1.43 | — | — |
| Dec 2026 | $1.36 | — | — |
| Nov 2026 | $1.25 | — | — |
| Aug 2026 | $1.30 | $1.55 | +19.2% |
| May 2026 | $1.25 | $1.46 | +16.8% |
| Feb 2026 | $1.18 | $1.67 | +41.5% |
| Nov 2025 | $1.27 | $1.27 | 0.0% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| Apr 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $2.60 | — | — | $508.3M | — | — | — |
| Sep 2028 | $1.82 | — | — | $487.1M | — | — | — |
| Jun 2028 | $1.70 | — | — | $463.0M | — | — | — |
| Mar 2028 | $1.55 | — | — | $437.4M | — | — | — |
| Dec 2027 | $1.88 | — | — | $428.2M | — | — | — |
| Sep 2027 | $1.59 | — | — | $413.6M | — | — | — |
| Jun 2027 | $1.52 | — | — | $405.9M | — | — | — |
| Mar 2027 | $1.43 | — | — | $389.6M | — | — | — |
| Dec 2026 | $1.36 | — | — | $371.1M | — | — | — |
| Nov 5, 2026 | $1.25 | — | — | $360.9M | — | — | — |
| Aug 6, 2026 | $1.30 | $1.55 | +19.2% | $363.2M | $388.2M | +6.9% | −0.4% |
| May 7, 2026 | $1.25 | $1.46 | +16.8% | $354.5M | $377.3M | +6.4% | +5.6% |
| Feb 26, 2026 | $1.18 | $1.67 | +41.5% | $367.0M | $406.8M | +10.8% | −0.4% |
| Nov 6, 2025 | $1.27 | $1.27 | 0.0% | $368.0M | $384.0M | +4.4% | −6.2% |
| Aug 6, 2025 | |||||||
| May 7, 2025 | |||||||
| Feb 26, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Jul 31, 2024 | |||||||
| May 2, 2024 | |||||||
| Feb 22, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 4, 2023 | |||||||
| Feb 23, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 4, 2022 | |||||||
| Apr 29, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Jul 28, 2021 | |||||||
| May 4, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Jul 30, 2020 | |||||||
| Apr 30, 2020 | |||||||
| Feb 25, 2020 | |||||||
| Oct 31, 2019 | |||||||
| Jul 25, 2019 | |||||||
| Apr 30, 2019 | |||||||
| Feb 19, 2019 | |||||||
| Oct 30, 2018 | |||||||
| Aug 1, 2018 | |||||||
| May 2, 2018 | |||||||
| Feb 26, 2018 | |||||||
| Nov 2, 2017 | |||||||
| Aug 1, 2017 | |||||||
| May 2, 2017 | |||||||
| Feb 21, 2017 | |||||||
| Nov 1, 2016 | |||||||
| Aug 4, 2016 | |||||||
| May 3, 2016 | |||||||
| Feb 22, 2016 | |||||||
| Nov 4, 2015 | |||||||
| Aug 4, 2015 |